Gedeon Richter PLC (BUD:RICHTER)

Gedeon Richter Revenue

Gedeon Richter had revenue of 241.39B HUF in the quarter ending June 30, 2026, a decrease of -0.04%. This brings the company's total for the last twelve months to 925.05B, up 2.40% year-over-year. In the year 2025, Gedeon Richter had annual revenue of 928.96B with 8.33% growth. That makes Gedeon Richter the 3,969th largest company in the world by revenue and 4th in Hungary.

• Revenue (ttm): 925.05B
• Revenue Growth: +2.40%
• P/S Ratio: 2.56
• Revenue / Employee: 82.93M
• Employees: 11,155
• Market Cap: 2.37T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals - Women's Healthcare (WHC) 328.57B 35.0%
• Pharmaceuticals - Neuropsychiatry (CNS) 264.70B 28.2%
• Pharmaceuticals - General Medicines (GM) 249.53B 26.6%
• Pharmaceuticals - Biotechnology (BIO) 64.16B 6.8%
• Other 25.58B 2.7%
• Pharmaceuticals - Pharma Other 6.99B 0.7%

By Geography

Chart

• Europe 550.52B 59.3%
• North America 276.38B 29.8%
• APAC 54.71B 5.9%
• Latin America 38.31B 4.1%
• Rest of The World 9.05B 1.0%

Fiscal year ended Dec 31, 2025 See the full Gedeon Richter breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	928.96B	71.42B	8.33%
Dec 31, 2024	857.55B	52.39B	6.51%
Dec 31, 2023	805.16B	2.40B	0.30%
Dec 31, 2022	802.76B	172.16B	27.30%
Dec 31, 2021	630.60B	63.82B	11.26%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error